ST葫芦娃(605199.SH)获得吸入用异丙托溴铵溶液药品注册证书

Core Viewpoint - ST Huluwawa (605199.SH) has received the drug registration certificate for inhaled ipratropium bromide solution from the National Medical Products Administration, which will enrich the company's product line and positively impact its development [1] Group 1 - The company has obtained a drug registration certificate for inhaled ipratropium bromide solution [1] - This approval is expected to enhance the company's product offerings [1] - The development is seen as a positive step for the company's growth [1]